The Technology Development Board (TDB) under the Department of Science and Technology, Government of India, has signed an agreement with Primary Healthtech, for a project titled “IoT-enabled Point-of-Care Blood Testing Device for Affordable and Accessible Healthcare powered by AI/ML algorithms.”
Founded by Sahil Jagnani and Ankit Choudhury, alumni of IIT Guwahati, the company emerged from a multidisciplinary collaboration of doctors, researchers, entrepreneurs, professors, and students committed to creating low-cost diagnostic solutions for underserved communities.
Their early research, supported by BIRAC, led to the development of Mobilab—a portable, battery-operated clinical chemistry analyzer. Mobilab is IoT-enabled, integrates AI/ML algorithms, and can test more than 25 health parameters related to kidney, liver, heart, vitamins, and cancer.
The company holds a patent titled “A transmittance-based system/kit for point-of-care quantification,” transferred from IIT Guwahati, and has filed six additional patents covering integrated mixers, assay development, centrifuges, and proprietary optical systems. Mobilab has already undergone trials on 10,000 patients and has recently received a CDSCO manufacturing license.
The new project will focus on enhancing the existing M1 prototype to perform five tests simultaneously, thereby reducing patient waiting times and enabling commercial-scale manufacturing.
The next-generation Mobilab will cover a wider set of tests, including Hemoglobin, Creatinine, Bilirubin, Cholesterol, Triglycerides, Uric Acid, Glucose, and GGT, among others.
Commenting on the initiative, Rajesh Kumar Pathak, Secretary of TDB, said:
“Ensuring quality healthcare access in rural and remote regions is a national priority. This project not only addresses affordability and accessibility but also showcases India’s ability to develop indigenous, AI-powered diagnostic solutions for primary healthcare.”
The promoters of Primary Healthtech Pvt. Ltd. expressed their appreciation, stating: “TDB’s support will accelerate our journey from lab innovation to large-scale deployment. With Mobilab, we hope to bridge the healthcare gap in rural and underserved communities, making advanced diagnostics available at the point of care, anywhere in India.”
